These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12661449)

  • 1. [Oral therapy instead of enemas].
    MMW Fortschr Med; 2003 Feb; 145(8):56. PubMed ID: 12661449
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-ASA for ulcerative colitis.
    Meyers S; Janowitz HD
    N Engl J Med; 1988 Jun; 318(24):1620-1. PubMed ID: 3287160
    [No Abstract]   [Full Text] [Related]  

  • 3. [Ulcerative colitis. Acute episode].
    Reissmann A; Bischoff SC; Fleig W
    Z Gastroenterol; 2004 Sep; 42(9):994-8. PubMed ID: 15455271
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ulcerative colitis. Maintenance therapy].
    Kruis W; Schreiber S
    Z Gastroenterol; 2004 Sep; 42(9):1011-4. PubMed ID: 15455275
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral balsalazide (Colazal) for ulcerative colitis.
    Med Lett Drugs Ther; 2001 Jul; 43(1109):62-3. PubMed ID: 11468602
    [No Abstract]   [Full Text] [Related]  

  • 6. Novel 5-aminosalicylic acid formulations in ulcerative colitis: old dog, new tricks.
    Wilson J
    Gastroenterol Nurs; 2008; 31(4):286-92. PubMed ID: 18708833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of ulcerative colitis.
    Goggins M
    Ir Med J; 1993; 86(4):112-3. PubMed ID: 8360037
    [No Abstract]   [Full Text] [Related]  

  • 8. Colonic targeting of aminosalicylates for the treatment of ulcerative colitis.
    Klotz U
    Dig Liver Dis; 2005 Jun; 37(6):381-8. PubMed ID: 15893274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of ulcerative colitis with oral mesalamine: advances in drug formulation, efficacy expectations and dose response, compliance, and chemoprevention.
    Sandborn WJ
    Rev Gastroenterol Disord; 2006; 6(2):97-105. PubMed ID: 16699478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized observer-blind 2-year trial of azathioprine monotherapy versus azathioprine and olsalazine for the maintenance of remission of steroid-dependent ulcerative colitis.
    Mantzaris GJ; Sfakianakis M; Archavlis E; Petraki K; Christidou A; Karagiannidis A; Triadaphyllou G
    Am J Gastroenterol; 2004 Jun; 99(6):1122-8. PubMed ID: 15180735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review article: evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis.
    Cohen RD
    Aliment Pharmacol Ther; 2006 Aug; 24(3):465-74. PubMed ID: 16886912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study.
    Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Papageorgiou A; Vassiliadis T; Giouleme O; Evgenidis N
    Aliment Pharmacol Ther; 2006 May; 23(10):1443-53. PubMed ID: 16669959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review article: induction therapy for patients with active ulcerative colitis.
    Travis SP
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():10-6. PubMed ID: 16939424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mesalazine granules instead of tablets. New ulcerative colitis therapy confirmed also in general practice routine].
    MMW Fortschr Med; 2004 Jun; 146(24):53. PubMed ID: 15366501
    [No Abstract]   [Full Text] [Related]  

  • 15. The short- and long-term safety of 5-aminosalicylate products in the treatment of ulcerative colitis.
    Baker DE; Kane S
    Rev Gastroenterol Disord; 2004; 4(2):86-91. PubMed ID: 15185719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When less is not more but at least equivalent.
    Holland S
    Inflamm Bowel Dis; 2004 Nov; 10(6):890-1. PubMed ID: 15626910
    [No Abstract]   [Full Text] [Related]  

  • 17. Are patients with inflammatory bowel disease receiving optimal care?
    Reddy SI; Friedman S; Telford JJ; Strate L; Ookubo R; Banks PA
    Am J Gastroenterol; 2005 Jun; 100(6):1357-61. PubMed ID: 15929770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: maintenance therapy in patients with ulcerative colitis.
    Orchard T; Probert CS; Keshav S
    Aliment Pharmacol Ther; 2006 Sep; 24 Suppl 1():17-22. PubMed ID: 16939425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review article: problematic proctitis and distal colitis.
    Gionchetti P; Rizzello F; Morselli C; Campieri M
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():93-6. PubMed ID: 15352902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reformulation of an aminosalicylate: an example of the importance of pill burden on medical compliance rates.
    Osterman MT; Lichtenstein GR
    Methods Find Exp Clin Pharmacol; 2009; 31(1):41-6. PubMed ID: 19357797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.